1. Overexpression and correlation of HIF-2α, VEGFA and EphA2 in residual hepatocellular carcinoma following high-intensity focused ultrasound treatment: Implications for tumor recurrence and progression
   Lun Wu et al, 2017 CrossRef
2. Anticancer effects of ginsenoside Rg3 (Review).
   Mengyao Sun et al, 2017, Int J Mol Med CrossRef
3. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway
   Jin Jiang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
4. Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy
   Ana Cavaco et al, 2017, IJMS CrossRef
5. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes
   Hongyan Han et al, 2017, European Journal of Pharmacology CrossRef
6. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex
   Honglong Wei et al, 2017, Cancer Sci CrossRef
7. Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma
   Shujie Duan, 2017, CBM CrossRef
8. Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling
   Nanmu Yang et al, 2016 CrossRef
9. Functional mechanism of Ginsenosides on tumor growth and metastasis
   Tianli Chen et al, 2018, Saudi Journal of Biological Sciences CrossRef
10. Saponins from Chinese Medicines as Anticancer Agents.
    Xiao-Huang Xu et al, 2016, Molecules CrossRef
11. Stereoisomers of Saponins in Panax notoginseng (Sanqi): A Review
    Ming Peng et al, 2018, Front. Pharmacol. CrossRef
12. Antitumor efficacy of Lf modified daunorubicin plus honokiol liposomes in treatment of brain glioma
    Shuang Liu et al, 2017, European Journal of Pharmaceutical Sciences CrossRef
13. Evidence of Vasculogenic Mimicry in a Palpebral Melanocytoma in a Dog
    L. Nordio et al, 2018, Journal of Comparative Pathology CrossRef
14. Angiogenesis in pancreatic cancer: current research status and clinical implications.
    Shuo Li et al, 2019, Angiogenesis CrossRef
15. Role of angiogenesis in pancreatic cancer biology and therapy
    Zheng Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
16. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1
    Jinliang Li et al, 2019, Experimental and Molecular Pathology CrossRef
17. Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
    Maryam Nakhjavani et al, 2019, Medicines CrossRef
18. Knockdown of USF1 Inhibits the Vasculogenic Mimicry of Glioma Cells via Stimulating SNHG16/miR-212-3p and linc00667/miR-429 Axis
    Di Wang et al, 2019, Molecular Therapy - Nucleic Acids CrossRef
19. RhoC/ROCK2 promotes vasculogenic mimicry formation primarily through ERK/MMPs in hepatocellular carcinoma
    Ji-Gang Zhang et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
20. The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
    Giovanni Gravina et al, 2019, Cancers CrossRef
21. Role of the Family of Ephs and Ephrins in Cell-Cell Communication in Cancer
    Mohamed Amessou et al, 2015 CrossRef
22. Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting Angiogenesis
    Shen Hu et al, 2019, Analytical Cellular Pathology CrossRef
23. Effects of ginsenoside compound K combined with cisplatin on the proliferation, apoptosis and epithelial mesenchymal transition in MCF-7 cells of human breast cancer
    Keqiang Zhang et al, 2016, Pharmaceutical Biology CrossRef
24. Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers
    Qian Zhao et al, 2016, Eur J Drug Metab Pharmacokinet CrossRef
25. MicroRNA-140 regulates cell growth and invasion in pancreatic duct adenocarcinoma by targeting iASPP
    Shuai Liang et al, 2016, Acta Biochim Biophys Sin CrossRef
26. Stereoselective pharmacokinetic and metabolism studies of 20(S)- and 20(R)-ginsenoside Rg 3 epimers in rat plasma by liquid chromatography-electrospray ionization mass spectrometry
    Ming Peng et al, 2016, Journal of Pharmaceutical and Biomedical Analysis CrossRef
27. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
    Daniel Delgado-Bellido et al, 2017, Mol Cancer CrossRef
28. Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
    Yue Li et al, 0 CrossRef
29. Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
    Lízbeth Ayala-Domínguez et al, 2019, Front. Oncol. CrossRef
30. Silencing of Mig-7 expression inhibits in-vitro invasiveness and vasculogenic mimicry of human glioma U87 Cells
    Zhigang Pan et al, 2019, NeuroReport CrossRef
31. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
    Hua Luo et al, 2019, Chin Med CrossRef
32. RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply
    Liang Kong et al, 2020, Cancer Sci CrossRef
33. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy
    Sanya Haiaty et al, 2020, IUBMB Life CrossRef
34. Ginsenoside Rg3 suppresses the growth of gemcitabine‐resistant pancreatic cancer cells by upregulating lncRNA‐CASC2 and activating PTEN signaling
    Jifeng Zou et al, 2020, J Biochem Mol Toxicol CrossRef
35. Vasculogenic mimicry in carcinogenesis and clinical applications
    Qingxi Luo et al, 2020, J Hematol Oncol CrossRef
36. Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting
    Peace Mabeta, 2020, Biomedicine & Pharmacotherapy CrossRef
37. Rhodocetin-αβ selectively breaks the endothelial barrier of the tumor vasculature in HT1080 fibrosarcoma and A431 epidermoid carcinoma tumor models
    Stephan Niland et al, 2018, Oncotarget CrossRef
38. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy
    Dan Huang et al, 2016, Oncotarget CrossRef
39. Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
    Vito Longo et al, 2016, Oncotarget CrossRef
40. Vascular mimicry: changing the therapeutic paradigms in cancer
    Nazila Fathi Maroufi et al, 2020, Mol Biol Rep CrossRef
41. Ginsenoside Rg3 Inhibits the Growth of Osteosarcoma and Attenuates Metastasis through the Wnt/β-Catenin and EMT Signaling Pathway.
    Xiaohan Mao et al, 2020, Evid Based Complement Alternat Med CrossRef
42. Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.
    Wei Geng et al, 2018, Mol Med Rep CrossRef
43. The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas.
    Tieju Liu et al, 2020, Int J Oncol CrossRef
44. Role of EphA2‑PI3K signaling in vasculogenic mimicry induced by cancer‑associated fibroblasts in gastric cancer cells
    Hee Kim et al, 2019, Oncol Lett CrossRef
45. Ziyuglycoside II exerts antiproliferative and antimetastasis effects on hepatocellular carcinoma cells
    Wanqin Liao et al, 2020 CrossRef
46. Natural compounds against doxorubicin‐induced cardiotoxicity: A review on the involvement of Nrf2/ ARE signaling pathway
    Fatemeh Yarmohammadi et al, 2020, Phytotherapy Research CrossRef
47. Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides
    Sang Yeol Lee, 2021, Biomedicines CrossRef
48. Insights into the antitumor mechanism of ginsenosides Rg3.
    Zongyu Liu et al, 2021, Mol Biol Rep CrossRef
49. Cleavable poly(ethylene glycol) branched chain-modified Antheraea pernyi silk fibroin as a gene delivery carrier
    Xueping Liu et al, 2021, Nanomedicine CrossRef
50. Role of RHOC in evaluating an adverse prognosis in patients with glioma and its potential prognostic value
    Bo Zhang et al, 2021, Mol Clin Oncol CrossRef
51. Downregulation of Astrocyte Elevated Gene-1 Expression Combined with All-Trans Retinoic Acid Inhibits Development of Vasculogenic Mimicry and Angiogenesis in Glioma
    Chen Liang et al, 2022, CURR MED SCI CrossRef
52. The effects of Ginsenosides on PI3K/AKT signaling pathway
    Soudeh Ghafouri-Fard et al, 2022, Mol Biol Rep CrossRef
53. Effect of ginsenoside Rg3 on proliferation and apoptosis of 786-0 cells and AktmTORSTAT3 signaling in renal carcinoma
    Hongwei LI et al, 2022, Food Sci. Technol CrossRef
54. The Anticancer Activity and Mechanisms of Ginsenosides: An Updated Review
    Hongwei Chen et al, 2020, eFood CrossRef
55. Histochemical Staining of Vasculogenic Mimicry
    Saber Imani et al, 2022 CrossRef
56. How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?
    Yulia Kirdeeva et al, 2022, Pharmaceuticals CrossRef
57. Saponins as cytotoxic agents: an update (2010–2021). Part II—Triterpene saponins
    Irma Podolak et al, 2022, Phytochem Rev CrossRef
58. Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs
    Haitao Hu et al, 2022, International Immunopharmacology CrossRef
59. Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry
    Elena Andreucci et al, 2022, Cancer Metastasis Rev CrossRef
60. The therapeutic potential of natural products for treating pancreatic cancer
    Xia He et al, 2022, Front. Pharmacol. CrossRef
61. Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells
    Deok-Soo Han et al, 2022, Sci Rep CrossRef
62. Anticancer effect and molecular mechanism of ginsenoside Rg3 in various cancer types
    Yuzhu Wang et al, 2023, Intelligent Pharmacy CrossRef
63. Vasculogenic mimicry
    E.Z. Lapkina et al, 2023, Arkh. patol. CrossRef
64. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma
    Xufan Cai et al, 2024, Phytomedicine CrossRef
65. Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications
    Lei Wu et al, 2024, CTMC CrossRef
66. Ginsenosides in cancer: Proliferation, metastasis, and drug resistance
    Yi Yang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
67. Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2/FGFR1 signaling pathway
    Huina Wang et al, 2024, Phytomedicine CrossRef
68. Erythropoietin-induced hepatocyte receptor A2 regulates effect of pyroptosis on gastrointestinal colorectal cancer occurrence and metastasis resistance
    Yu-Kun Zhang et al, 2024, World J Gastrointest Oncol CrossRef
69. Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1α/LARS1/mTOR axis
    Tingting Zhao et al, 2025, Phytomedicine CrossRef